The death of 66 children in The Gambia so far after taking Indian cough syrup is putting India's pharmaceutical industry under pressure again.
In recent years, the "pharmacy of the world" has repeatedly been the target of investigations, for example by the American drug agency, which denounced the sometimes hair-raising production conditions, especially for imitation products.
A few years ago, the European Union triggered a trade dispute with India when it blacklisted around 700 Indian imitation products.
India even canceled the next round of trade talks with the EU.
Christopher Hein
Business correspondent for South Asia/Pacific based in Singapore.
Follow I follow
Now the company Maiden Pharmaceuticals from New Delhi is in the spotlight.
His juices are said to have been deadly loaded.
In the West African country of just 2.4 million people, volunteers are trying to go from house to house to collect the dangerous juices.